Dr Fiona See
Research Officer
| telephone | +61 3 9288 3563 |
| facsmilie | +61 3 9288 2581 |
| fionasee @ unimelb.edu.au |
Profile
Dr Fiona See is a Postdoctoral Fellow based in Columbia University, USA whose research interests are in the field of assessing the benefits of stem cell therapy in relation to heart disease.
University of Melbourne find an expert profile
Professional Activities:
Member of American Heart Association Basic Cardiovascular Sciences Council. Member of Cardiac Society of Australia and New Zealand
Qualifications
BSc (Hons) LLB
Selected Publications
- See FCP, Thomas G, Way KJ, Tzanidis A, Kompa A, Lewis D, Itescu S & Krum H. 2004. p38 mitrogen-activated
- Witkowski P, Seki T, Xiang G, Martens T, Sandermeijer H, See F, Bhagat G, Schuster M, Hardy MA & Itescu S. 2007. A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model. Journal of Cardiovascular Pharmacology. 50 (6): 633-40.
- Martens TP, See F, Schuster MD, Sondermeijer HP, Hefti MM, Zannettino A, Granthos S, Seki T & Itescu S. 2006. Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nature Clinical Practice Cardiovascular Medicine. 3 (Supplement 1): S18-S22.
- Martin JH, Kelly DJ, Zhang Y, Gauci SA, Cox AJ, See FCP, Krum H, Wilkinson-Berka JLA & Gilbert RE. 2005. Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-B. Cardiovascular Research. 65: 694-701.
- See F, Kompa A, Martin J, Lewis DA & Krum H. 2005. Fibrosis as a therapeutic target post-myocardial infarction. Current Pharmaceutical Design. 11: 477-487.
- Xiang G, Seki T, Schuster M, Witkowski P, Boyle A, See FCP, Martens TP, Kocher AA, Sondermeijer H, Krum H & Itescu S. 2005. Catalytic Degradation of Vitamin D Up-regulated Protein 1 mRNA Enhances Cardiomyocyte Survival and Prevents Left Ventricular Remodelling after Myocardial Ischemia*. Journal of Biological Chemistry. 280 (47): 39394-39402.
- See F, Kompa A & Krum H. 2004. p38 MAP kinase as a therapeutic target in cardiovascular disease. Drug Discovery Today. 1: 149-154.
- Tzanidis A, Thomas G, Onan D, Autelitano DJ, See FCP, Kelly DJ, Gilbert RE, Hannan R & Krum H. 2003. Direct actions of urotensin II on the heart implications for cardiac fibrosis and hypertrophy. Circulation Research. 93 (93): 246-253.